Glenn Whaley bought $32k of IMUX
Chief Financial Officer at IMMUNIC, INC.. 45,000 shares at an average of $0.71, traded Jun 3, 2025, filed Jun 4, 2025.
Score components
- +22RoleCFO
- +5Trade size$32k at market
- +10Relative to holdingsHoldings up 89%
- +8Price context63% below the 52-week high
- +15Cluster6 insiders buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001193805-25-000788, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| May 30, 2025 | AGrant or award Common Stock | +25,000 | $0.56 | $14k | 50,510 | Jun 4, 2025 |
| Jun 3, 2025 | POpen-market purchase Common Stock | +45,000 | $0.71 | $32k | 95,510 | Jun 4, 2025 |
Related signals
Other insiders at IMMUNIC, INC. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 58Moderate | IMMUNIC, INC. | Daniel Vitt CEO and Director | $12k 15,000 shares | +107% | |
| 51Moderate | IMMUNIC, INC. | Jason Tardio President and COO | $9,884 12,512 shares | - | |
| 53Moderate | IMMUNIC, INC. | Duane Nash Executive Chairman | $17k 20,000 shares | +125% | |
| 51Moderate | IMMUNIC, INC. | Jason Tardio President and COO | $9,884 12,512 shares | - | |
| 58Moderate | IMMUNIC, INC. | Daniel Vitt CEO and Director | $12k 15,000 shares | +107% | |
| 56Moderate | IMMUNIC, INC. | Joerg Neermann director | $77k 100,000 shares | +100% | |
| 58Moderate | IMMUNIC, INC. | Richard Alan Rudick director | $100k 143,075 shares | +164% | |
| 33Weak | IMUXbuy IMMUNIC, INC. | Richard Alan Rudick director | $100k 87,300 shares | - |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.